Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon

file-20210122-17-uivv7s

People who use drugs understand drugs and drug use in ways that are often different to the way knowledge of drug use is constructed within the dominant medico-legal discourse. Their experiences are, more often than not, represented in negative ways within dominant discourse, a disconnect that can create adverse consequences for people who use drugs, through the production of stigma and shame leading to poor health and social outcomes. A key difference in how drugs are understood by people who use drugs is the capacity of the former to recognize positive aspects of drug use and create more agentic subjectivities for themselves concerning the use of drugs. Using a thematic analysis of the online forum Australian Drug Discussion, hosted by Bluelight.org, we identify positive drug stories and the contexts of their emergence, as subversions or modifications of dominant understandings. We argue that positive understandings of drug use, as well as recognition of the way their expression serves to generate agency for people who use drugs within or against the confines of dominant discourse, may provide opportunities to limit further the harms flowing from stigmatization and negativity.

Click here to read the full article by Dr Martin Williams & Dr Stephen Bright

Image: Jonathan Carmichael

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.

PRISM

We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.

Newsletter

Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt
0

Start typing and press Enter to search